Location:
OpenCRlSPR-1 nuclease

OpenCRISPR-1 Nuclease


Product Introduction

OpenCRISPR-1 is the world's first gene editor designed entirely by artificial intelligence. The research team at Profluent first systematically mined microbial genomic data totaling 26.2 terabases to construct the CRISPR-Cas Atlas database, containing over 1.24 million CRISPR operons. The Cas9 sequence diversity within this database is more than four times greater than that found in UniProt. Based on this massive dataset, the researchers fine-tuned the ProGen2 protein language model to generate 4.8 million novel CRISPR-associated protein sequences. Through rigorous screening and functional validation, they ultimately identified OpenCRISPR-1 as the top-performing candidate.

OpenCRISPR-1 consists of 1380 amino acids and maintains the typical bilobal architecture framework of type II Cas9 nucleases. However, its amino acid sequence differs from SpCas9 at over 400 positions and shares no more than 86% sequence similarity with any known naturally occurring CRISPR-associated protein. Despite this high degree of sequence divergence, AlphaFold2 structural predictions indicate that it fully retains key functional domains, including the HNH and RuvC nuclease domains. OpenCRISPR-1 recognizes the same 5'-NGG-3' PAM sequence as SpCas9 and can directly use standard SpCas9 sgRNAs, making it a plug-and-play replacement for existing SpCas9-based approaches.


Product Specifications

Parameter

Specification

Source

Recombinant expression in E. coli

Molecular Weight

~160 kDa

Concentration

20 μM

PAM Sequence

5'-NGG-3'

Cleavage Site

3 bp upstream of PAM

Cleavage Product

Blunt-ended DSB

Similarity to SpCas9

<86%

Specificity

Higher than SpCas9

Purity

≥95% (SDS-PAGE)

Endotoxin

<1 EU/μg

Storage Buffer

50 mM Tris-HCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 50% Glycerol

10× Reaction Buffer

50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl₂, 100 μg/ml BSA, pH 7.9

Storage Conditions

Long-term storage at -80°C; short-term storage at -20°C

Product Specifications

Specifications

Catalog Number

Concentration

Volume

100 pmol

GR101601

20 μM

5 μL

500 pmol

GR101602

20 μM

25 μL

2500 pmol

GR101603

20 μM

125 μL

Application Scenarios

High-Specificity Gene Editing: Applications requiring reduced off-target risk.

Therapeutic Editing: Cell and gene therapy research and development.

Research Applications: As a substitute for SpCas9.

Intellectual Property Circumvention: Patent pathways independent of natural CRISPR systems.

AI Protein Design Validation: Validating the functionality of AI-designed proteins.

References

Ruffolo JA, et al. (2025). Design of highly functional genome editors by modelling CRISPR–Cas sequences. Nature. doi:10.1038/s41586-025-09298-z.